TrialJournal for immunotherapy of cancer2022

Single-cell immune signature for detecting early-stage HCC and early assessing anti-PD-1 immunotherapy efficacy.

Jiawei Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.